Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

Walt Bogdanich
Author: Walt Bogdanich

Written by

Walt Bogdanich

in

Clinical Trials, Drugs (Pharmaceuticals), Eisai Co Ltd, Elderly, Eli Lilly and Company, Food and Drug Administration, Genetics and Heredity, Government Accountability Office, Hemorrhagic Stroke, Institute for Clinical and Economic Review, Kisunla, Leqembi (Drug), Medicine and Health, Novartis AG, Retirement Communities and Assisted Living, United States, Villages, The (Fla)
←Joe Biden Goes Dark Brandon To Put Donald Trump’s ‘Concept Of A Plan’ On Blast
4 Can’t-Miss Towns in an Often Overlooked Corner of Japan→

More posts

  • ‘Artificial’s Ike Barinholtz Teases What Makes His “Menacing” Elon Musk Performance “A Little Ridiculous”

  • Kelly Clarkson says a Brooklyn store snubbed her. The shop says the item she wanted wasn’t for sale.

  • Idaho College Murder Victims Honored at Friends’ Wedding Who Found Their Bodies

  • Robert Pattinson Approached Chris Hansen Portrayal In ‘Primetime’ As “A Fan”: “I Was Trying To Make Him Cool”

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube